Review
Open access
Aug 2026
Advances in Clinical Research on CRISPR-Cas9 for the Treatment of Common Monogenic Diseases
The success of CRISPR-Cas9 in monogenic diseases represents the prelude to precision medicine, whereas conquering complex diseases will require systematic leaps in target discovery, delivery technology, and safety profiles.
Wentao Pan
· MedScien · 0 citations